Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-EN | Version v4-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2023-02-16 | 2023-02-14 |
| Drug Identification Number | 00392618 | 00392618 |
| Brand name | MAGNESIUM SULFATE INJ 20% USP | MAGNESIUM SULFATE INJ 20% USP |
| Common or Proper name | MAGNESIUM | MAGNESIUM |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | MAGNESIUM SULFATE | MAGNESIUM SULFATE |
| Strength(s) | 200MG | 200MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10ML | 10ML |
| ATC code | B05XA | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2023-01-18 | 2023-01-18 |
| Estimated end date | 2023-02-03 | 2023-02-03 |
| Actual end date | 2023-02-02 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Baxter item: 5421. Product is available on allocation based on 90% of historical volumes. | Baxter item: 5421. Product is available on allocation based on 90% of historical volumes. |
| Health Canada comments |